100 related articles for article (PubMed ID: 6191671)
1. [Japanese-French cooperation in tumor pharmacotherapy: 1970-1990].
Mathé G
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1050-70. PubMed ID: 6191671
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
[TBL] [Abstract][Full Text] [Related]
3. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
Warrell RP
Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
[TBL] [Abstract][Full Text] [Related]
4. Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
Dantchev D; Slioussartchouk V; Paintrand M; Hayat M; Bourut C; Mathé G
Cancer Treat Rep; 1979 May; 63(5):875-88. PubMed ID: 455329
[TBL] [Abstract][Full Text] [Related]
5. Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
Dantchev D; Balercia G; Bourut C; Anjo A; Maral R; Mathé G
Biomed Pharmacother; 1984; 38(7):322-8. PubMed ID: 6240996
[TBL] [Abstract][Full Text] [Related]
6. [Pilot studies with aclacinomycin in patients with breast cancer or gastrointestinal tumors].
Rainer H; Gössinger H; Lenzhofer R; Moser K; Schneeweiss B
Wien Med Wochenschr; 1983; 133(7):183-7. PubMed ID: 6868630
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Dorval T; Ribaud P
Biomed Pharmacother; 1984; 38(7):328-31. PubMed ID: 6596962
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
Kumai K; Kubota T; Ishibiki K; Abe O
Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
[TBL] [Abstract][Full Text] [Related]
9. [Pirarubicin (THP-adriamycin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2819-27. PubMed ID: 3046496
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene].
Tominaga T; Kitamura M; Yoshida Y; Kosaki G
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800
[TBL] [Abstract][Full Text] [Related]
11. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L
Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137
[TBL] [Abstract][Full Text] [Related]
12. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
13. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
14. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
[TBL] [Abstract][Full Text] [Related]
16. Clinical studies of aclacinomycin A (ACM).
Majima H; Ohta K
Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of aclacinomycin A.
Van Echo DA; Whitacre MY; Aisner J; Applefeld MM; Wiernik PH
Cancer Treat Rep; 1982 May; 66(5):1127-32. PubMed ID: 6952961
[TBL] [Abstract][Full Text] [Related]
18. Experimental studies on aclacinomycin.
Tone H; Nishida H; Takeuchi T; Umezawa H
Drugs Exp Clin Res; 1985; 11(1):9-15. PubMed ID: 2424701
[TBL] [Abstract][Full Text] [Related]
19. [New anthracyclines].
Ogawa M; Ariyoshi Y
Gan To Kagaku Ryoho; 1993 Jan; 20(1):27-33. PubMed ID: 8422185
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
